DNAnexus Completes $68 Million Financing
Summary
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--DNAnexus, Inc., the leader in biomedical informatics and data management, today announced closing a $68 million financing. “We are excited to support DNAnexus’ ongoing mission to accelerate science and medical discoveries by democratizing access to data through a global network.” The financing supports the deployment of DNAnexus Apollo™, an advanced platform for multi-omics and clinical data exploration, analysis, and discovery. The Apollo Platform uses the DNAnexus global network, providing secure and compliant infrastructure with access to tools and datasets within a collaborative environment. “The next wave of biomedical insights will be derived from cross-institutional collaborations that generate massive volumes of clinical and multi-omics data. Innovatus adheres to an investment strategy that identifies disruptive and growth opportunities across multiple asset categories with a unifying theme of capital preservation, income generation, and upside optionality.
Funding
Classifications
AskAI Classifications
LabelsLinked Companies
